Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis

Background The conventional antiviral treatment of chronic hepatitis related to hepatitis C virus (HCV) often leads to anemia. In this case, it is necessary to reduce ribavirin dose or stop treatment, thus reducing the rate of sustained virological response.